comparemela.com

Robert Bonow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mortality Signal Emerges 2 Years After Valve-in-Valve TAVR for Failed SAVR

Alternative to redo surgery associated with several-fold increase in deaths, HF hospitalization

New yorkUnited statesNew jerseyShinobu itagakiRobert bonowNicole louVinay guduguntlaNorthwestern university feinberg school of medicineIcahn school of medicine at mount sinaiMount sinai hospitalIcahn schoolMount sinaiNew york cityNorthwestern university feinberg schoolMedpage today

High-Sensitivity Troponin Test May Overestimate Risk in PE

On the other hand, conventional assays did predict a complicated course in acute PE

United statesRobert bonowDavid jimVinay guduguntlaNicole louEuropean society of cardiologyNorthwestern university feinberg school of medicineHospital ramNorthwestern university feinberg schoolMedpage today

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

With only 2-year follow-up it’s challenging to interpret long-term outcomes, says Yousif Ahmad.

United statesRobert bonowYousif ahmadTsuyoshi kanekoWashington university school of medicineMd northwestern university feinberg school of medicinePhd yale university school of medicinePhd laval university quebec heart lung instituteJosep rodQuebec heartLung instituteYale university schoolNew havenEvolut low riskWashington university schoolNorthwestern university feinberg school

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

If the device is approved, “I am very excited to put this to use because we have an unmet need,” Pinak Shah says.

City ofUnited kingdomNew yorkUnited statesRobert bonowVinod thouraniPinak shahRebecca hahnBernard prendergastPresbyterian columbia university irving medical centerMd piedmont heart instituteDrug administrationMd northwestern university feinberg school of medicinePiedmont heart instituteColumbia university irving medical centerNorthwestern university feinberg school

Trilogy TAVR Safe, Effective in Aortic Regurgitation

The Trilogy transcatheter aortic valve replacement system was safe and effective for high-risk surgical patients with aortic regurgitation, improving LV remodeling and function, in the ALIGN-AR trial.

United statesRobert bonowVinod thouraniNorthwestern university feinberg school of medicineJenavalve technologyPiedmont heart institute in atlantaDrug administrationJenavalve trilogyPiedmont heart instituteTranscatheter cardiovascular therapeuticsNorthwestern university feinberg schoolAortic insufficiencyImplanted device cardiologyTranscatheter aortic valve replacement tavrRanscatheter aortic valve implantation taviPercutaneous aortic valve replacement

vimarsana © 2020. All Rights Reserved.